Health Care • Biotechnology: Laboratory Analytical Instruments
$165.78 ▲ +0.45
(+0.27%)
MKT CAP: $18.50B • VOL: 1.53M
52W L $81 52W H $169
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$139
MEDIAN
$186
MEAN
$189
HIGH
$225
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE RVTY TAPE
RVTY // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $200.59 | $190.65 | 2025-02-14 | $150.86 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $208.88 | $195.62 | 2025-02-06 | $155.83 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $188.99 | $182.36 | 2025-01-29 | $159.15 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $169.10 | — | 2025-01-17 | $162.46 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $145.89 | $157.49 | 2025-01-09 | $147.54 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $197.28 | $172.41 | 2024-12-18 | $144.23 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $160.81 | $167.44 | 2024-12-04 | $154.18 | -4.3% | 48% | C |